Sign in

CIK 0000873303

  • Large accelerated filer

Sarepta Therapeutics, Inc.

Sign in to watch
Ticker
SRPT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
930797222
Phone
+1 617-274-4000
Business address
215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
Former names
Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
  1. 4 Grant or award Chief Operating Officer acquired 143,875 shares (grant or award)
  2. 4 Grant or award EVP, General Counsel acquired 118,875 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Shares withheld for taxes Chief Financial Officer gave up 327 shares (to pay taxes)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Exercise or conversion Director acquired 12,350 shares (option exercise)
  9. 4 Exercise or conversion Director acquired 20,246 shares (option exercise)
  10. 4 Open-market sale Director sold 2,491 shares at $99.64 ($248,203)
  11. 4 Grant or award Director acquired 2,383 shares (grant or award)
  12. 4 Grant or award Director acquired 2,383 shares (grant or award)
  13. 4 Grant or award Director acquired 2,383 shares (grant or award)
  14. 4 Shares withheld for taxes EVP, General Counsel gave up 491 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Financial Officer gave up 3,941 shares (to pay taxes)
  16. 4 Grant or award Director acquired 2,383 shares (grant or award)
  17. 4 Grant or award Director acquired 2,383 shares (grant or award)
  18. 4 Shares withheld for taxes Chief Tech Ops Officer gave up 523 shares (to pay taxes)
  19. 4 Shares withheld for taxes Head of R&D, CSO gave up 3,463 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Customer Officer gave up 3,733 shares (to pay taxes)

Page 3 of 34 · 672 filings